Target intelligence / Profile preview

Long Interspersed Nuclear Element-1 Open Reading Frame 1 protein (LINE-1 ORF1p)

Target
LINE-1 ORF1p
Molecular classification
RNA-binding protein, Chaperone, Retrotransposon protein
01

Overview

Long Interspersed Nuclear Element-1 Open Reading Frame 1 protein (LINE-1 ORF1p) is a 40 kDa RNA-binding protein and nucleic acid chaperone encoded by the LINE-1 retrotransposon, the only active autonomous mobile genetic element in the human genome. It plays a critical role in the LINE-1 life cycle by binding to LINE-1 mRNA to form a ribonucleoprotein (RNP) complex, which is essential for the transport and integration of new genetic copies. While typically silenced in healthy adult somatic tissues through epigenetic mechanisms, ORF1p is highly overexpressed in a vast majority of human cancers, including pancreatic, colorectal, and ovarian malignancies. In the tumor microenvironment, ORF1p has been shown to shield repetitive RNAs from innate immune sensors like RIG-I and MAVS, thereby suppressing anti-tumor immune responses and promoting viral mimicry evasion. Due to its high tumor specificity, ORF1p is an emerging pan-cancer biomarker for early detection and monitoring via liquid biopsy. Therapeutic strategies targeting ORF1p include small molecule inhibitors of its chaperone activity, such as the experimental compounds B7 and C1, as well as DNA vaccines and targeted protein degraders. These interventions aim to inhibit tumor growth, restore innate immune signaling, and address the chronic inflammation associated with LINE-1 activation in aging and autoimmune diseases.

Other names
L1ORF1pp40LINE-1 retrotransposable element ORF1 proteinORF1p
02

Mechanism of action

Inhibition of nucleic acid chaperone activity, suppression of protein expression, and induction of immune responses via vaccination or targeted degradation.

03

Biological functions

RetrotranspositionRNA bindingNucleic acid chaperone activityRibonucleoprotein complex formationImmune evasionRNA transport
04

Disease associations

CancerInflammationAutoimmune diseaseNeurodegenerative diseaseAging
05

Safety considerations

Off-target effects on other RNA-binding proteinsInduction of cellular stress responsesPotential impact on germline or developmental processes
06

Interacting drugs

B7

4 more in the full profile.

07

Biomarkers

Plasma ORF1pSerum ORF1pORF1p autoantibodiesORF1p immunohistochemistry (IHC)

Beyond the preview

Go deeper on Long Interspersed Nuclear Element-1 Open Reading Frame 1 protein (LINE-1 ORF1p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long Interspersed Nuclear Element-1 Open Reading Frame 1 protein (LINE-1 ORF1p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call